Account
Inquiry
XCE Tirzepatide is a high-purity peptide compound with triple agonist activity targeting glucagon receptor, glucose-dependent insulinotropic polypeptide receptor, and glucagon-like peptide-1 receptor (GLP-1R). This pharmaceutical grade material is specifically designed for research purposes only.
The XCE Tirzepatide compound demonstrates significant potential in metabolic research applications. When administered through subcutaneous injection, it has shown to improve glucose tolerance through activation of GIP or GLP-1 receptors. In research settings, it has demonstrated effects on weight reduction and energy expenditure through glucagon receptor activation.
Our XCE Tirzepatide is produced under strict quality control standards, ensuring consistent high purity and reliable performance for research applications. The product is supplied in sealed vials with appropriate packaging to maintain stability.
For research institutions requiring larger quantities, we offer bulk supply options with flexible packaging configurations. Custom formulations and concentrations can be arranged to meet specific research requirements.
XCE Tirzepatide represents an important tool for researchers investigating metabolic disorders and related conditions. Its triple agonist mechanism offers unique research opportunities in the field of endocrinology and metabolic regulation.
